László Gopcsa

4PUBLICATIONS
18CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 27, 2026
Fecal Microbiota Transplantation and Microbiota-Based Therapeutics in Allogeneic Hematopoietic Stem Cell Transplantation: Current Evidence and Future Directions.

|Jan 12, 2026
Adoptive T-cell therapies for persistent COVID-19 in immunocompromised patients: Comparison of IFN-γ virus-specific T-cell therapy and CD45RA+ T-cell depleted donor lymphocyte infusion.

László Gopcsa, Borisz Rabán Petrik, Bálint Gergely Szabó

|Jul 06, 2023
Effective virus-specific T-cell therapy for high-risk SARS-CoV-2 infections in hematopoietic stem cell transplant recipients: initial case studies and literature review.

László Gopcsa, Marienn Réti, Hajnalka Andrikovics

|Nov 19, 2021
Common points of therapeutic intervention in COVID-19 and in allogeneic hematopoietic stem cell transplantation associated severe cytokine release syndrome.

László Gopcsa, Ilona Bobek, Gabriella Bekő

Pageof 1

Frequent Collaborators

2 joint publications

Bálint Gergely Szabó

2 joint publications

János Sinkó

1 joint publications

Borisz Rabán Petrik

1 joint publications

Marienn Réti